Subclinical Hypothyroidism, Kidney, and Heart from Normal to Uremic Milieu
- PMID: 37433213
- DOI: 10.1089/met.2023.0057
Subclinical Hypothyroidism, Kidney, and Heart from Normal to Uremic Milieu
Abstract
Thyroid hormone (TH) imbalances, particularly subclinical hypothyroidism (SCHT), are associated with chronic kidney disease (CKD) and end-stage kidney disease (ESKD). SCHT is more prevalent in CKD and ESKD patients than in the general population, and this condition increases the risk of cardiovascular disease (CVD) morbidity and mortality. The risk of CVD is higher in CKD and ESKD patients compared with the general population. Traditional and nontraditional risk factors, including TH abnormalities, contribute to the high CVD burden in CKD and ESKD patients. The review discusses the link between CKD and hypothyroidism, with a focus on SCHT, and the mechanisms that lead to CVD burden.
Keywords: cardiovascular risk; chronic kidney disease; subclinical hypothyroidism; vascular calcification.
Similar articles
-
Functional Abnormalities and Thyroid Nodules in Patients with End-stage Renal Disease.In Vivo. 2017 Nov-Dec;31(6):1203-1208. doi: 10.21873/invivo.11191. In Vivo. 2017. PMID: 29102947 Free PMC article.
-
Atherosclerotic vascular disease is more prevalent among black ESKD patients on long-term CAPD in South Africa.BMC Nephrol. 2019 Oct 30;20(1):399. doi: 10.1186/s12882-019-1583-8. BMC Nephrol. 2019. PMID: 31666030 Free PMC article.
-
Demographic, clinical characteristics and cardiovascular disease burden in a Portuguese cohort of older chronic kidney disease patients.J Bras Nefrol. 2019 Jan-Mar;41(1):29-37. doi: 10.1590/2175-8239-JBN-2018-0120. Epub 2019 Jan 10. J Bras Nefrol. 2019. PMID: 31063177 Free PMC article.
-
Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients.Nephrol Dial Transplant. 2015 May;30(5):724-37. doi: 10.1093/ndt/gfu024. Epub 2014 Feb 25. Nephrol Dial Transplant. 2015. PMID: 24574542 Free PMC article. Review.
-
Cardiovascular Risk Prediction in Chronic Kidney Disease.Am J Nephrol. 2022;53(10):730-739. doi: 10.1159/000528560. Epub 2022 Dec 8. Am J Nephrol. 2022. PMID: 36481730 Review.
Cited by
-
Thyroid hormone replacement therapy in dialysis/renal insufficiency patients.Front Endocrinol (Lausanne). 2025 Feb 24;16:1540802. doi: 10.3389/fendo.2025.1540802. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40078580 Free PMC article. Review.
-
Levothyroxine treatment for subclinical hypothyroidism and risk of adverse renal outcomes: a population-based cohort study.CMAJ. 2025 Jul 27;197(26):E744-E753. doi: 10.1503/cmaj.250356. CMAJ. 2025. PMID: 40721243 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical